Plasma Rich in Growth Factors for the Treatment of Cicatrizing Conjunctivitis

Autor: de la Sen-Corcuera B, Montero-Iruzubieta J, Sánchez-Ávila RM, Orive G, Anitua E, Caro-Magdaleno M, Merayo-Lloves J

Publikováno v: Clinical Ophthalmology, Vol Volume 14, Pp 1619-1627 (2020)

Borja de la Sen-Corcuera,1,2 Jesús Montero-Iruzubieta,3,4 Ronald M Sánchez-Ávila,1,5 Gorka Orive,1,2 Eduardo Anitua,1,2 Manuel Caro-Magdaleno,4 Jesús Merayo-Lloves5 1Biotechnology Institute (BTI), Vitoria, Spain; 2University Institute for Regener

Externí odkaz: https://doaj.org/article/f0cb3e1acbf148d8b22b16d9a9564bde

Plasma rich in growth factors eye drops to treat secondary ocular surface disorders in patients with glaucoma

Autor: Sánchez-Avila RM, Merayo-Lloves J, Fernández ML, Rodríguez Gutiérrez LA, Rodríguez-Calvo PP, Fernández-Vega Cueto A, Muruzabal F, Orive G, Anitua E

Publikováno v: International Medical Case Reports Journal, Vol Volume 11, Pp 97-103 (2018)

Ronald M Sánchez-Avila,1 Jesus Merayo-Lloves,1 Maria Laura Fernández,1,2 Luis Alberto Rodríguez-Gutiérrez,1 Pedro Pablo Rodríguez-Calvo,1 Andres Fernández-Vega Cueto,1 Francisco Muruzabal,3,4 Gorka Orive,3–6 Eduardo Anitua3,4 1University Inst

Externí odkaz: https://doaj.org/article/f57e371ffdf24a11a39165a87bb544fa

Use of autologous plasma rich in growth factors fibrin membrane in the surgical management of ocular surface diseases.

Autor: Sabater AL; Department of Ophthalmology, Bascom Palmer Eye Institute, Ocular Surface Center, University of Miami Miller School of Medicine, Miami, USA., Mousa HM; Steven and Frances Foster Distinguished Chair in Ocular Immunology, Duke Eye Center for Ocular Immunology, Duke University School of Medicine, Durham, NC, 27705, USA., Quinones X; Department of Ophthalmology, Bascom Palmer Eye Institute, Ocular Surface Center, University of Miami Miller School of Medicine, Miami, USA., Valenzuela F; Department of Ophthalmology, Bascom Palmer Eye Institute, Ocular Surface Center, University of Miami Miller School of Medicine, Miami, USA., Sanchez Avila RM; Fernández-Vega University Institute, Ophthalmologic Research Foundation, University of Oviedo, Oviedo, Spain., Orive G; Foundation Eduardo Anitua, Victoria, Spain.; Biotechnology Institute (BTI), Victoria, Spain.; NanoBioCel Group, Laboratory of Pharmaceutics, School of Pharmacy, University of the Basque Country UPV/EHU, Paseo de la Universidad 7, 01006, Vitoria-Gasteiz, Spain.; Biomedical Research Networking Centre in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Vitoria-Gasteiz, Spain., Anitua E; Foundation Eduardo Anitua, Victoria, Spain.; Biotechnology Institute (BTI), Victoria, Spain., Merayo J; Fernández-Vega University Institute, Ophthalmologic Research Foundation, University of Oviedo, Oviedo, Spain., Perez VL; Department of Ophthalmology, Bascom Palmer Eye Institute, Ocular Surface Center, University of Miami Miller School of Medicine, Miami, USA. victor.perez.quinones@duke.edu.; Steven and Frances Foster Distinguished Chair in Ocular Immunology, Duke Eye Center for Ocular Immunology, Duke University School of Medicine, Durham, NC, 27705, USA. victor.perez.quinones@duke.edu.

Publikováno v: International ophthalmology [Int Ophthalmol] 2021 Jul; Vol. 41 (7), pp. 2347-2358. Date of Electronic Publication: 2021 Mar 21.

Plasma rich in growth factors for the treatment of dry eye from patients with graft versus host diseases.

Autor: Sanchez-Avila RM; Instituto Universitario Fernández-Vega, Fundación de Investigación Oftalmológica, Oviedo, Spain., Merayo-Lloves J; Instituto Universitario Fernández-Vega, Fundación de Investigación Oftalmológica, Oviedo, Spain., Muruzabal F; University Institute for Regenerative Medicine and Oral Implantology-UIRMI, UPV/EHU-Fundación Eduardo Anitua, Vitoria, Spain.; BTI Biotechnology Institute, Vitoria-Gasteiz, Spain., Orive G; University Institute for Regenerative Medicine and Oral Implantology-UIRMI, UPV/EHU-Fundación Eduardo Anitua, Vitoria, Spain.; BTI Biotechnology Institute, Vitoria-Gasteiz, Spain., Anitua E; University Institute for Regenerative Medicine and Oral Implantology-UIRMI, UPV/EHU-Fundación Eduardo Anitua, Vitoria, Spain.; BTI Biotechnology Institute, Vitoria-Gasteiz, Spain.

Publikováno v: European journal of ophthalmology [Eur J Ophthalmol] 2020 Jan; Vol. 30 (1), pp. 94-103. Date of Electronic Publication: 2018 Dec 26.

Treatment of patients with neurotrophic keratitis stages 2 and 3 with plasma rich in growth factors (PRGF-Endoret) eye-drops.

Autor: Sanchez-Avila RM; Instituto Universitario Fernández-Vega, Fundación de Investigación Oftalmológica, Universidad de Oviedo, Oviedo, Spain. ronald.sanchezavila@gmail.com., Merayo-Lloves J; Instituto Universitario Fernández-Vega, Fundación de Investigación Oftalmológica, Universidad de Oviedo, Oviedo, Spain. merayo@fio.as., Riestra AC; Instituto Universitario Fernández-Vega, Fundación de Investigación Oftalmológica, Universidad de Oviedo, Oviedo, Spain., Fernandez-Vega Cueto L; Instituto Universitario Fernández-Vega, Fundación de Investigación Oftalmológica, Universidad de Oviedo, Oviedo, Spain.; Moorfields Eye Hospital, London, UK., Anitua E; Fundación Eduardo Anitua, Vitoria, Spain.; Biotechnology Institute (BTI), Jacinto Quincoces, 39, 01007, Vitoria, Spain., Begoña L; Fundación Eduardo Anitua, Vitoria, Spain.; Biotechnology Institute (BTI), Jacinto Quincoces, 39, 01007, Vitoria, Spain., Muruzabal F; Fundación Eduardo Anitua, Vitoria, Spain.; Biotechnology Institute (BTI), Jacinto Quincoces, 39, 01007, Vitoria, Spain., Orive G; Biotechnology Institute (BTI), Jacinto Quincoces, 39, 01007, Vitoria, Spain. gorka.orive@bti-implant.es.; NanoBioCel Group, Laboratory of Pharmaceutics, School of Pharmacy, University of the Basque Country (UPV/EHU), 01006, Vitoria-Gasteiz, Spain. gorka.orive@bti-implant.es.; Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Vitoria-Gasteiz, Spain. gorka.orive@bti-implant.es.

Publikováno v: International ophthalmology [Int Ophthalmol] 2018 Jun; Vol. 38 (3), pp. 1193-1204. Date of Electronic Publication: 2017 Jun 15.